ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
Plazomicin (Achaogen) financial post-mortem: #PassPASTEUR
Push! Pull! Push! Pull! / Highlights from Davos 2018
Two new oral drugs for gonorrhea!
Limits on measuring the impact of rapid antimicrobial susceptibility testing (AST)
Lancet: 10-20-30 targets to address AMR by 2030
Categories of resistance: MDR, XDR, PDR, UDR, and (new!) DTR
Draft FDA guidance on anti-infectives for children: It’s (mostly) all about PK and safety
Melinta goes bankrupt / Never let a good crisis go to waste
COVID-19 and the Long-Term Trajectory of AMR Efforts: Wellcome Trust Deep Dive
Modeling the value of an effective antibiotic — Megiddo et al.
FDA Workshop: Animal models in support of narrow-spectrum agents for A. baumannii and P. aeruginosa
FDA: Early endpoints and late endpoints suggest a path to global regulatory convergence (Bart et al.)
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet








